SHSu Su Thae Hnit

Su Su Thae Hnit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Su Su Thae Hnit has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Small Extracellular Vesicles in Triple-Negative Breast Cancer: From Immune Checkpoint Modulation to Clinical Applications

    by Fatemeh Pashizeh, Victoria Ie Ching Tan, Simon Chang-Hao Tsao, Dhanusha Sabanathan, Jessica Da Gama Duarte, Su Su Thae Hnit, Yuling Wang

    Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Among current treatment strategies, immune checkpoint inhibitor (ICI) therapy has shown promising clinical efficacy and is FDA-approved for TNBC. Immune checkpoints (ICPs) are regulatory proteins on immune cells that modulate immune responses to prevent overactivation and autoimmunity. Small extracellular vesicles (sEVs), a subtype of extracellular vesicles secreted by all cell types, mirror the molecular characteristics of their cells of origin. Tumor-derived sEVs can carry ICPs such as PD-L1, which interact with PD-1 on immune cells, mimicking the function of membrane-bound PD-L1 and contributing to immune evasion. sEVs derived from immune cells may carry ICPs like PD-1 and CTLA-4, potentially influencing immune responses and immunotherapy outcomes within the TNBC tumor microenvironment. Despite growing interest, the mechanisms by which ICP-bearing (ICP+) sEVs interact with immune and tumor cells in TNBC remain poorly understood. Existing reviews have explored ICPs and sEVs in cancer broadly, but few focus specifically on TNBC or the role of ICP+ sEVs in modulating its microenvironment. This review highlights the emerging role of ICP+ sEVs in TNBC progression, immune modulation, and immunotherapy resistance. We also examine their potential as biomarkers for disease monitoring and treatment response. Finally, we discuss future directions for ICP+ sEVs in clinical applications, including overcoming ICI therapy resistance in TNBC.

  • Proteomics Study of Breast Cancer-Derived Small Extracellular Vesicles: Unveiling Potential Cancer Biomarkers

    by Cao Hoang Long Ngo, Su Su Thae Hnit, Wei Zhang, Xin Feng, Victoria Ie Ching Tan, Lianghai Hu, Simon Chang-Hao Tsao, Yuling Wang

    Small extracellular vesicles (sEVs) are lipid-bilayer-enclosed vesicles secreted by cells into the extracellular environment, carrying a variety of biomolecules, including proteins that reflect the molecular profile of their cell of origin. In particular, cancer-derived sEVs hold significant potential for cancer diagnosis due to their unique biomolecular content. In this study, we utilized mass spectrometry to profile the protein expression in plasma-derived sEVs from both healthy controls (HCs) and breast cancer (BC) patients with the aim of discovering new protein biomarkers for potential BC diagnosis. Through the cross-validation of differentially expressed proteins between the two independent cohorts, we identified nine proteins that were significantly upregulated in BC-derived sEVs. Further validation using online gene expression data sets, Western blot, and ELISA revealed that OIT3 was upregulated in BC tissue compared to HC tissue, suggesting its potential as a novel BC biomarker. These findings contribute to advancing the knowledge of proteins within sEVs, as well as offering promising avenues for the use of sEVs as biomarkers in future cancer diagnostic applications.


  • On-Chip Profiling of Bacterially Infected Host Cell-Derived Small Extracellular Vesicles by Surface-Enhanced Raman Scattering

    by Nana Lyu, Amin Hassanzadeh-Barforoushi, Wei Zhang, Cao Hoang Long Ngo, Su Su Thae Hnit, David W. Inglis, Yuling Wang

    Small extracellular vesicles (sEVs) are membrane-bound nanoparticles (Pseudomonas aeruginosa strain PAO1. This platform integrates host-pathogen coculture with on-chip sEV capture and multiplexed molecular profiling of host cell-derived sEVs. A two-layer modular design enables stepwise cell loading, controlled coculture, and efficient sEV capture through hydrophobic interactions between the sEV membrane and silane-modified polymer that modified on the chip. Multiplexed surface-enhanced Raman scattering (SERS) nanotags allow simultaneous detection of key sEV biomarkers from A549 cells (CD81, EGFR, EpCAM), and PAO1 (oprF). Through SERS mapping, molecular signatures across sEVs are spatially resolved, providing insights into compositional changes in sEVs following PAO1 exposure. By minimizing direct bacterial contact and relying on diffusion-driven capture, the system more closely mimics physiological infection processes.


  • Harvest Time-Dependent Changes in the Composition and Function of Microglia-Derived Small Extracellular Vesicles

    by Muhammad Waqas Salim, Wei Zhang, Su Su Thae Hnit, Karthik S. Kamath, Lyndsey E. Collins-Praino, Andrew Care, Yuling Wang

    Microglia are dynamic macrophage-like cells that survey the central nervous system (CNS) and mediate neuroinflammatory responses. Even under homeostatic conditions, they exhibit phenotypic plasticity in response to environmental cues. Microglia-derived small extracellular vesicles (sEVs), which are lipid bilayer vesicles encapsulating proteins, lipids, and nucleic acids, reflect the physiological state of their parent cells and influence recipient cell function. Although increasing attention has been given to their roles in neuroinflammation, neurodegeneration, and intercellular communication, the impact of experimental variables, particularly harvest timing, on microglial sEV composition remains poorly understood. This study investigated how different harvest durations (24, 48, and 72 h) influence the molecular and functional properties of sEVs released by BV2 microglial cells. sEVs were isolated via ultracentrifugation and characterized for particle size, yield, RNA and protein content, surface marker expression, and proteomic profile. While sEV size and morphology remained consistent across time points, particle yield and RNA content increased significantly with prolonged harvest, peaking at 72 h. Classical sEV markers (CD9, CD81, TSG101) were consistently expressed, suggesting stable vesicle identity. However, proteomic profiling revealed a time-dependent shift in cargo, with an increase in unique proteins and enrichment of stress- and neurodegeneration-related pathways at 72 h. Functional assays further demonstrated that sEVs collected at this time point reduced viability in both microglial and neuronal cells. Together, these findings highlight harvest time as a critical determinant of microglial sEV composition and bioactivity, with implications for their use in diagnostics, therapeutics, and drug delivery applications.


  • Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles

    by Chloe Duffield, Laura M. Rey Gomez, Su Su Thae Hnit, Wei Zhang, Simon Chang-Hao Tsao, David W. Inglis, Yuling Wang

    Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.


  • Open Access

    Inhibition of Dormant Lung Cancer Cell Reactivation by Punica Granatum Peel and Dioscorea Nipponica: Involving MYC, SKP2 and p27

    by Su Su Thae Hnit, Ling Bi, Chanlu Xie, Ling Xu, Yi Zhong, Ming Yang, Yan Wang, Qihan Dong

    Introduction: Dormant cancer cells, capable of reactivating from the G0 phase, drive tumor recurrence and therapy resistance. Current clinical strategies targeting dormancy remain limited. This study evaluates Punica granatum peel (PGP) and Dioscorea Nipponica (DN) for their ability to sustain dormancy in lung cancer cells and inhibit reactivation. Methods: Dormancy was induced in A549 and H460 lung cancer cells via contact inhibition or serum deprivation. Subcutaneous and orthotopic xenograft mouse models were employed. Cells and mice were treated with PGP, DN, or their combination. SYBR Green assays, flow cytometry, and immunoblotting assessed DNA synthesis, cell cycle phases, and protein expression (p27, SKP2, cMYC, AURORA A, SUPT16H, SSRP1). Results: Both PGP and DN significantly inhibited DNA synthesis and cell cycle re-entry (G0-to-G1 transition) in vitro. In vivo, tumor volume and weight decreased by 26– 50% (p < 0.05) in treated mice. Treatments upregulated p27 while downregulating SKP2, cMYC, AURORA A, SUPT16H, and SSRP1. No synergistic effect was observed, but additive efficacy (Combination Index ≈1) was noted at a 10:1 PGP:DN ratio. Discussion: PGP and DN sustain dormancy by modulating key cell cycle regulators, highlighting their potential to reduce recurrence and combat drug resistance. These findings underscore the therapeutic promise of traditional Chinese medicines in managing dormant cancer cells. Future studies should identify active compounds and validate mechanisms in advanced models.


  • A New Strategy to Modify Glass for Capture and Detection of Small Extracellular Vesicles

    by Cao Hoang Long Ngo, Su Su Thae Hnit, Amin Hassanzadeh-Barforoushi, Faiza Chowdhury, Wei Zhang, David W. Inglis, Simon Chang-Hao Tsao, Yuling Wang

    Small extracellular vesicles (sEVs) are nanoscale lipid bilayer vesicles secreted from all types of cells to the extracellular environment. They inherit membrane proteins from their parent cells, making them one of the key biomaterials or biomarkers for disease diagnosis. Microfluidics is emerging as a promising platform for sEV capture, with many methods relying on the modification to a glass substrate for efficient capture. In this study, we propose a new, one-step surface modification method, using silane─poly(ethylene glycol) (PEG) - 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), named as silane-PEG-DSPE, to capture sEVs on glass. In this design, silane group attaches to hydroxylated glass surface via covalent bond between Si-(OEt)3 and hydroxyl (OH) group. DSPE then binds to sEVs with distearyl chains firmly anchoring to the vesicle lipid membrane. We determined the optimal conditions for silane-PEG-DSPE modification and tested the efficiency of silane-PEG-DSPE in capturing sEVs by fluorescent imaging. Additionally, surface-enhanced Raman scattering (SERS) demonstrated that the EpCAM-positive sEVs were presented on the glass surface. This suggests that the platform is applicable for sEV detection using various methods, including fluorescent imaging and SERS. Furthermore, we have demonstrated that SERS can detect sEVs from breast cancer (BC) patient plasma with high specificity and sensitivity (as low as 1.6 × 107 particles/mL). Additionally, our analysis reveals a significantly higher expression of EpCAM in BC-derived sEVs compared with those obtained from healthy individuals. Thus, we postulate that the proposed method will find broad applications in the future, particularly as an effective tool in cancer diagnosis.


  • Improved biostability of gold nanostars for enhanced intercellular interactions

    by Anastasiia Tukova, Su Su Thae Hnit, Dan Wang, Megan Lord, Alison Rodger, Yuling Wang

    Gold nanostars with 4-mercaptobenzoic acid as SERS nanotags show high biostability in cell culture media, with/without BSA precoating. SERS imaging reveals higher uptake by immune vs cancer cells; with protein precoating showing little effect.


  • Improving SERS biosensors for the analysis of ovarian cancer-derived small extracellular vesicles

    by Long Ngo, Wei Zhang, Su Su Thae Hnit, Yuling Wang

    An improved SERS assay was reported to detect ovarian cancer derived-small extracellular vesicles (sEVs) down to 1.5 × 10 5 particles per μL. The surface protein biomarkers on sEVs were profiled, showing high sensitivity and specificity of the SERS assay.